Kronos Worldwide Inc
Chemours’s Interest Expense Is Set to Decline
Chemours’s (CC) interest expense has remained steady for the past two years.
Chemours Increases Fluoropolymer Prices
On March 29, 2018, Chemours (CC) announced a price increase for its range of fluoropolymer products across the globe.
Chemours Has Continued Its Upward Momentum in 2017
So far in 2017, Chemours (CC) stock has given investors stunning returns. The stock has risen 128% YTD and outperformed SPY.
Why Is Chemours’ Dividend Yield Low?
Since Chemours hasn’t increased its dividend rate since 4Q15, we can expect the company to pay a dividend of $0.12 for fiscal 2017.
Chemours: Analyzing Its 3Q17 Dividend
On September 15, 2017, Chemours (CC) will pay the 3Q17 dividend on its outstanding common shares. It has declared a cash dividend of $0.03 per share.
Chemours Stock Fell despite Strong Earnings in 2Q17
Chemours (CC) reported its 2Q17 earnings on August 2, 2017, after the markets closed. The company’s management held a conference call on August 3, 2017.
Understanding the Recent Rise in Chemours Stock
Since the beginning of 2017, Chemours (CC) stock has given a tremendous performance, gaining 66.6% YTD as of June 22.
Chemours by Valuation: Where CC Stands among Peers
On June 23, 2017, Chemours one-year forward PE (price-to-earnings) multiple was 10.0x, as compared to KRO’s one-year forward PE multiple of 16.30x.
How Comfortable Is Chemours in Servicing Its Debt?
Chemours has $1.4 billion variable interest rate debt. Now that the Fed has begun raising the interest rates, CC’s interest expenses could go up.
Behind Chemours’ Debt Development since Its Spin-Off
When Chemours (CC) was spun off from DuPont (DD) on July 1, 2015, many believed that CC was doomed to fail.
How PEUGX Managed to Place in the Middle of the Pack in 2015
What saved PEUGX in 2015 were its picks from the consumer staples, telecom services, and utilities sectors.
Healthcare Spoiled PEUGX’s Year-to-Date 2015
In the trailing-one-year period, PEUGX has returned 1.0%, while from November’s end until December 22, the fund has fallen 4.5%.
Why October Wasn’t the Month for the Putnam Europe Equity Fund
The Putnam Europe Equity Fund rose 4.5% in October 2015 from a month ago. It fell 4.7% in the three-month period ended October 30, 2015.
Why DuPont is spinning off its performance chemicals segment
DuPont expects to enable both companies to pay dividends that in total equal DuPont’s dividend at the time of separation.